Assessment of Chromosomal DNA Fragmentation by Quinolones in an Isogenic Collection of Escherichia coli with Defined Resistance Mechanisms

Microbial Drug Resistance

Volumn 22, Issue 5, 2016, Pages 354-359

  Rodríguez Martínez, José Manuel ^a,b   Santiso, Rebeca ^c,d   Machuca, Jesús ^b,e   Bou, Germán ^b,c   Pascual, Álvaro ^a,b,e   Fernández, José Luis ^b,c,d  

^a UNIVERSITY OF SEVILLE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF A CORUÑA   (Spain)

^d Centro Oncologico de Galicia   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA FRAGMENTATION; DNA FRAGMENTATION ASSAY; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; BACTERIAL CHROMOSOME; CHEMISTRY; DRUG EFFECTS; ESCHERICHIA COLI INFECTION; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHENOTYPE; SENSITIVITY AND SPECIFICITY;

ANTI-BACTERIAL AGENTS; CHROMOSOMES, BACTERIAL; CIPROFLOXACIN; DNA FRAGMENTATION; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; SENSITIVITY AND SPECIFICITY;

EID: 84978252577     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2015.0298     Document Type: Article

References (16)

1. Briales, A., J.M. Rodriguez-Martinez, C. Velasco, P. Diaz de Alba, J. Dominguez-Herrera, J. Pachon, et al. 2011. In vitro effect of qnrA1, qnrB1, and qnrS1 genes on fluoroquinolone activity against isogenic Escherichia coli isolates with mutations in gyrA and parC. Antimicrob. Agents Chemother. 55:1266-1269
2. Drlica, K., M. Malik, R.J. Kerns, and X. Zhao. 2008. Quinolone-mediated bacterial death. Antimicrob. Agents Chemother. 52:385-392
3. Drlica, K., H. Hiasa, R. Kerns, M. Malik, A. Mustaev, and X. Zhao. 2009. Quinolones: action and resistance updated. Curr. Top. Med. Chem. 9:981-998
4. Erental, A., I. Sharon, and H. Engelberg-Kulka. 2012. Two programmed cell death systems in Escherichia coli: an apoptotic-like death is inhibited by the mazEF-mediated death pathway. PLoS Biol. 10:e1001281
5. Erental, A., Z. Kalderon, A. Saada, Y. Smith, and H. Engelberg-Kulka. 2014. Apoptosis-like death, an extreme SOS response in Escherichia coli. MBio 5:e01426-14
6. European Committee on Antimicrobial Susceptibility Testing (EUCAST). 2014. Clinical Breakpoints and Epidemiological Cutoff Values. Available at http://www.eucast.org/ clinical-breakpoints/. January 2014
7. Jacoby, G., J. Strahilevitz, and D. Hooper. 2014. Plasmid-mediated quinolone resistance. Microbiol. Spectr. 2:997-1003
8. Jakobsen, L., V. Cattoir, K.S. Jensen, A.M. Hammerum, P. Nordmann, and N. Frimodt-Moller. 2012. Impact of low-level fluoroquinolone resistance genes qnrA1, qnrB19 and qnrS1 on ciprofloxacin treatment of isogenic Escherichia coli strains in a murine urinary tract infection model. J. Antimicrob. Chemother. 67:2438-2444
9. Machuca, J., A. Briales, G. Labrador, P. Diaz-de-Alba, R. Lopez-Rojas, F. Docobo-Perez, et al. 2014. Interplay between plasmid-mediated and chromosomalmediated fluoroquinolone resistance and bacterial fitness in Escherichia coli. J. Antimicrob. Chemother. 69: 3203-3215
10. Machuca, J., A. Briales, P. Diaz-de-Alba, L. Martinez-Martinez, A. Pascual, and J.-M. Rodriguez-Martinez. 2015. Effect of the efflux pump QepA2 combined with chromosomally mediated mechanisms on quinolone resistance and bacterial fitness in Escherichia coli. J. Antimicrob. Chemother. 70:2524-2527
11. Machuca, J., A. Briales, P. Diaz-de-Alba, L. Martinez-Martinez, J.-M. Rodriguez-Martinez, and A. Pascual. 2015. Comparison of clinical categories for Escherichia coli harboring specific qnr and chromosomal-mediated fluoroquinolone resistance determinants according to CLSI and EUCAST. Enferm. Infecc. Microbiol. Clin. doi: 10.1016/ j.eimc.2015.01.019
12. Rodriguez-Martinez, J.-M., J. Machuca, J. Calvo, P. Diaz-de-Alba, C. Rodriguez-Mirones, C. Gimeno, et al. 2015. Challenges to accurate susceptibility testing and interpretation of quinolone resistance in Enterobacteriaceae: results of a Spanish multicentre study. J. Antimicrob. Chemother. 70:2038-2047
13. Rodriguez-Martinez, J.M., C. Velasco, I. Garcia, M.E. Cano, L. Martinez-Martinez, and A. Pascual. 2007. Mutant prevention concentrations of fluoroquinolones for Enterobacteriaceae expressing the plasmid-carried quinolone resistance determinant qnrA1. Antimicrob. Agents Chemother. 51:2236-2239
14. Santiso, R., M. Tamayo, J.L. Fernandez, M.D.C. Ferna ndez, F. Molina, R. Villanueva, et al. 2009. Rapid and simple determination of ciprofloxacin resistance in clinical strains of Escherichia coli. J. Clin. Microbiol. 47: 2593-2595
15. Tamayo, M., R. Santiso, J. Gosalvez, G. Bou, and J.L. Fernandez. 2009. Rapid assessment of the effect of ciprofloxacin on chromosomal DNA from Escherichia coli using an in situ DNA fragmentation assay. BMC Microbiol. 9:69
16. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-third Informational Supplement M100-S23. CLSI, Wayne, PA, 2013